Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine
September 9, 2024
New CLIA-certified lab ensures seamless transition from early assay development and testing to full companion diagnostics commercialization SANTA CLARA, Calif. -- Agilent Technologies Inc. , (NYSE: A) today announced the launch of its Biopharma CDx Services Lab (BCSL) in Carpinteria, California, following receipt of California State clinical laboratory license and Clinical Laboratory Improvement Amendments (CLIA) certificate of compliance. [...]
September 9, 2024
Pioneering automation project will enhance the speed and scale of brain disease research HOUSTON -- The Jan and Dan Duncan Neurological Research Institute (‘Duncan NRI’) at Texas Children’s Hospital, a world-class neuroscience research institute based in Houston, announces a groundbreaking advancement in its research capabilities, with the implementation of a state-of-the-art automation platform for human cellular model generation, [...]
September 9, 2024
FREDERICTON, New Brunswick – LuminUltra, the global leader in applied molecular diagnostics, today announced the acquisition of the legionella testing business assets of Genomadix Inc, along with rights to develop and commercialize further assays and test methods in water, energy and food and beverage markets globally using the Genomadix Cube™ qPCR (quantitative polymerase chain reaction) Platform. With [...]
IonOpticks partners with Adelis to accelerate global expansion and innovation
September 9, 2024
IonOpticks responds to growing global market needs for proteomics tools by partnering with Nordic private equity firm MELBOURNE, Australia and STOCKHOLM -- IonOpticks, a leading global producer of high-performance chromatography columns, announces its partnership with Adelis Equity Partners ("Adelis"). The Nordic private equity firm is renowned for partnering with and accelerating the growth of companies in their [...]
Hamamatsu Photonics has developed a new instrument, creating a unique class of cell analyzers
September 9, 2024
Imaging is a critical part of scientific research, from benchtop discovery to preclinical drug screening 1 . Building on our deep foundation of engineering and life science applications we have developed a new tool for advanced live cell image analysis. The CYTOQUBE Light-Sheet Microplate Cytometer (C15200-01RGBU) is designed to enable fast, information dense imaging of multi well [...]
MGI Tech Launches New Nanopore Sequencing Products with Advanced CycloneSEQ Technology
September 9, 2024
Shenzhen, China – MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technologies that drive innovation in life science, today announced the global rights to commercialize and distribute the new sequencing products CycloneSEQ-WT02* and CycloneSEQ-WY01*. With potential across different areas of genomics, CycloneSEQ™ technology integrates numerous technological improvements, including advanced protein [...]
September 9, 2024
The clarification is that it is the nomination committee of Nanologica AB that has presented the proposal to elect Alexandra Blomberg Montgomery to the board of directors of Nanologica AB. The nomination committee, consisting of Carl-Johan Spak (Flerie Invest AB), Lennart Francke (Swedbank Robur funds), and Kalle Olby (Vega Bianca AB), has in connection with [...]
September 9, 2024
Qkine is delighted to announce the appointment of Rob Nixon to its leadership team as Commercial Director and Paul Grafham as Chief Financial Officer. With years of experience working with fast-growing biotechs and life science reagent suppliers, these appointments will support the execution of the company’s growth strategies and expansion of its commercial operations globally. [...]
Oxford Nanopore announces participation in the PROGRESS study, with Yemaachi Biotech
September 8, 2024
A consortium of Yemaachi Biotech, Pediatric Oncology Units at Korle Bu Teaching Hospital, Komfo Anokye Teaching Hospital and Greater Accra Regional Hospital, and Newcastle University, have come together with Oxford Nanopore to support improved outcomes for childhood leukaemias in Ghana. Oxford Nanopore Technologies (Oxford Nanopore), the company delivering a new generation of molecular sensing technology [...]
September 6, 2024
CytoTronics, Inc., a pioneer of semiconductor-based platforms for discovery in cell biology, today announced a $13.5 million seed extension financing and the appointment of Sameer Rohatgi of LYFE Capital to their Board of Directors. The Series Seed 2 round was led by new investor, LYFE Capital, and existing investor Anzu Partners. New investors including Legend Star, RIT Venture Fund (Rochester [...]

